Corporate News 30-Dec-24
Biocon Biologics completes final remittance under acquisition agreement with Viatris
Biocon issued a statement stating that Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.
Previous News
Biocon Biologics expands access to insulin in Malaysia
( Corporate News - 30-Jun-25 09:06 )
Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
( Hot Pursuit - 27-Jun-25 12:18 )
Biocon Biologics partners with National Cancer Society of Malaysia
( Corporate News - 24-Jun-25 09:11 )
Biocon raises Rs 4,500 crore via QIP
( Hot Pursuit - 21-Jun-25 09:13 )
Restaurant Brands Asia Ltd leads gainers in 'A' group
( Hot Pursuit - 19-Jun-25 12:00 )
Biocon get facilities rated
( Corporate News - 18-Jun-25 09:41 )
Indices drift lower in early trade; breadth positive
( Market Commentary - Mid-Session 17-Jun-25 09:37 )
Biocon Ltd soars 3.52%, Gains for third straight session
( Hot Pursuit - 11-Jun-25 13:05 )
Biocon gets CDSCO approval for Liraglutide drug substance
( Hot Pursuit - 03-Jun-25 08:23 )
Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
( Corporate News - 22-May-25 09:19 )
Biocon Biologics and Yoshindo Inc. launch Ustekinumab Biosimilar in Japan
( Corporate News - 21-May-25 14:47 )
Other Stories
Jai Mata Glass to conduct board meeting
02-Jul-25 19:12
Jattashankar Industries to discuss results
02-Jul-25 19:12
GHCL to conduct board meeting
02-Jul-25 19:11
Mirza International schedules AGM
02-Jul-25 19:11
Sharp Investments announces board meeting date
02-Jul-25 19:11
Tata Communications to hold board meeting
02-Jul-25 19:11
Super Tannery to hold board meeting
02-Jul-25 19:10
RGF Capital Markets schedules board meeting
02-Jul-25 19:10
G G Engineering to convene AGM
02-Jul-25 19:10
Makers Laboratories to convene AGM
02-Jul-25 19:10
Back
Top
